Methodological development in medical technology assessment: The prospective approach

Research output: Contribution to journalJournal articlepeer-review

Standard

Methodological development in medical technology assessment : The prospective approach. / Møldrup, Claus; Traulsen, Janine Morgall; Peck, Jonathan C.

In: Journal of Risk Research, Vol. 6, No. 2, 01.03.2003, p. 95-112.

Research output: Contribution to journalJournal articlepeer-review

Harvard

Møldrup, C, Traulsen, JM & Peck, JC 2003, 'Methodological development in medical technology assessment: The prospective approach', Journal of Risk Research, vol. 6, no. 2, pp. 95-112. https://doi.org/10.1080/1366987032000078884

APA

Møldrup, C., Traulsen, J. M., & Peck, J. C. (2003). Methodological development in medical technology assessment: The prospective approach. Journal of Risk Research, 6(2), 95-112. https://doi.org/10.1080/1366987032000078884

Vancouver

Møldrup C, Traulsen JM, Peck JC. Methodological development in medical technology assessment: The prospective approach. Journal of Risk Research. 2003 Mar 1;6(2):95-112. https://doi.org/10.1080/1366987032000078884

Author

Møldrup, Claus ; Traulsen, Janine Morgall ; Peck, Jonathan C. / Methodological development in medical technology assessment : The prospective approach. In: Journal of Risk Research. 2003 ; Vol. 6, No. 2. pp. 95-112.

Bibtex

@article{8d20219e3ee741b4901aa81005851ab4,
title = "Methodological development in medical technology assessment: The prospective approach",
abstract = "Risks associated with modern drugs expand and develop beyond our existing control and perception mechanisms. New medicines have the ability to transform side effects from the traditional individual physical level to a societal level in the form of economic, political and ethical consequences. Existing assessment methods cannot capture or cope with the side effects we will experience with tomorrow's drugs. We interpret this as a sign of the need for on-going methodological developments within Medical Technology Assessment (MTA) to capture and include the as yet 'unknown' and 'unforeseen' economic, political and ethical risks of modern drugs. In this paper, we argue that a prospective inter-disciplinary approach should be applied to MTA as a form of 'early warning system', using the Delphi method combined with prospective scenarios to keep up with the changing characteristics of new drugs.",
keywords = "Early warning, Future, HTA, Medicine, MTA, Prospective, Technology assessment",
author = "Claus M{\o}ldrup and Traulsen, {Janine Morgall} and Peck, {Jonathan C.}",
year = "2003",
month = mar,
day = "1",
doi = "10.1080/1366987032000078884",
language = "English",
volume = "6",
pages = "95--112",
journal = "Journal of Risk Research",
issn = "1366-9877",
publisher = "Routledge",
number = "2",

}

RIS

TY - JOUR

T1 - Methodological development in medical technology assessment

T2 - The prospective approach

AU - Møldrup, Claus

AU - Traulsen, Janine Morgall

AU - Peck, Jonathan C.

PY - 2003/3/1

Y1 - 2003/3/1

N2 - Risks associated with modern drugs expand and develop beyond our existing control and perception mechanisms. New medicines have the ability to transform side effects from the traditional individual physical level to a societal level in the form of economic, political and ethical consequences. Existing assessment methods cannot capture or cope with the side effects we will experience with tomorrow's drugs. We interpret this as a sign of the need for on-going methodological developments within Medical Technology Assessment (MTA) to capture and include the as yet 'unknown' and 'unforeseen' economic, political and ethical risks of modern drugs. In this paper, we argue that a prospective inter-disciplinary approach should be applied to MTA as a form of 'early warning system', using the Delphi method combined with prospective scenarios to keep up with the changing characteristics of new drugs.

AB - Risks associated with modern drugs expand and develop beyond our existing control and perception mechanisms. New medicines have the ability to transform side effects from the traditional individual physical level to a societal level in the form of economic, political and ethical consequences. Existing assessment methods cannot capture or cope with the side effects we will experience with tomorrow's drugs. We interpret this as a sign of the need for on-going methodological developments within Medical Technology Assessment (MTA) to capture and include the as yet 'unknown' and 'unforeseen' economic, political and ethical risks of modern drugs. In this paper, we argue that a prospective inter-disciplinary approach should be applied to MTA as a form of 'early warning system', using the Delphi method combined with prospective scenarios to keep up with the changing characteristics of new drugs.

KW - Early warning

KW - Future

KW - HTA

KW - Medicine

KW - MTA

KW - Prospective

KW - Technology assessment

UR - http://www.scopus.com/inward/record.url?scp=0344440852&partnerID=8YFLogxK

U2 - 10.1080/1366987032000078884

DO - 10.1080/1366987032000078884

M3 - Journal article

AN - SCOPUS:0344440852

VL - 6

SP - 95

EP - 112

JO - Journal of Risk Research

JF - Journal of Risk Research

SN - 1366-9877

IS - 2

ER -

ID: 228774567